AbbVie (ABBV) Current Assets (2012 - 2026)

AbbVie (ABBV) has 15 years of Current Assets data on file, last reported at $33.5 billion in Q1 2026.

• Quarterly Current Assets rose 21.15% year-over-year to $33.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 billion (up 21.15% YoY) and the FY2025 annual result came in at $29.1 billion, up 13.6% from the prior year.
• Current Assets improved to $33.5 billion in Q1 2026 per ABBV's latest filing, from $29.1 billion in the prior quarter.
• Across five years, Current Assets topped out at $38.9 billion in Q1 2024 and bottomed at $25.6 billion in Q4 2024.
• The 5-year median for Current Assets is $29.1 billion (2025), against an average of $30.0 billion.
• The widest annual swing landed in 2024, when Current Assets surged 46.75%; it then fell 28.8% in 2025.
• Tracing ABBV's Current Assets over 5 years: stood at $28.5 billion in 2022, then advanced by 15.95% to $33.0 billion in 2023, then declined by 22.48% to $25.6 billion in 2024, then climbed by 13.6% to $29.1 billion in 2025, then grew by 15.37% to $33.5 billion in 2026.
• Per Business Quant, the three latest ABBV Current Assets figures stand at $33.5 billion (Q1 2026), $29.1 billion (Q4 2025), and $28.5 billion (Q3 2025).

Peer Comparison